I agree that this site is using cookies. You can find further informations here.
X
Chounta, Vasiliki
53  results:
Search for persons X
?
1

Pharmacokinetics and tolerability of cabotegravir and rilpi..:

Han, Kelong ; Gevorkyan, Hakop ; Sadik Shaik, Jafar...
Antimicrobial Agents and Chemotherapy.  68 (2024)  1 - p. , 2024
Link: https://doi.org/10.1128/..
 
?
2

Acceptability and tolerability of long-acting injectable ca..:

Lowenthal, Elizabeth D ; Chapman, Jennifer ; Ohrenschall, Rachel...
The Lancet HIV.  11 (2024)  4 - p. e222-e232 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Psychometric Validation of the Perception of Injection (PIN..:

Chounta, Vasiliki ; Byrnes, Hilary F. ; Henry-Szatkowski, Mickael...
Advances in Therapy.  40 (2023)  12 - p. 5300-5314 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Adherence to oral antiretroviral therapy in Canada, 2010–20..:

Angel, Jonathan B. ; Freilich, Jonatan ; Arthurs, Erin...
AIDS.  37 (2023)  13 - p. 2031-2040 , 2023
Link: https://doi.org/10.1097/..
 
?
5

Patient preferences and health state utilities associated w..:

Matza, Louis S. ; Howell, Timothy A. ; Chounta, Vasiliki.
Quality of Life Research.  32 (2022)  2 - p. 531-541 , 2022
Link: https://doi.org/10.1007/..
 
?
6

Indirect comparison of 48-week efficacy and safety of long-..:

Chounta, Vasiliki ; Snedecor, Sonya J. ; Wu, Sterling.
BMC Infectious Diseases.  22 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
7

Patient-Reported Outcomes Through 1 Year of an HIV-1 Clinic..:

Chounta, Vasiliki ; Overton, Edgar T. ; Mills, Anthony...
The Patient - Patient-Centered Outcomes Research.  14 (2021)  6 - p. 849-862 , 2021
Link: https://doi.org/10.1007/..
 
?
8

Week 96 extension results of a Phase 3 study evaluating lon..:

Swindells, Susan ; Lutz, Thomas ; Van Zyl, Lelanie...
AIDS.  36 (2021)  2 - p. 185-194 , 2021
Link: https://doi.org/10.1097/..
 
?
9

Cost-effectiveness of the long-acting regimen cabotegravir ..:

Parker, Ben ; Ward, Tom ; Hayward, Olivia...
PLOS ONE.  16 (2021)  2 - p. e0245955 , 2021
Link: https://doi.org/10.1371/..
 
?
10

Dose-related and contextual aspects of suboptimal adherence..:

Akinwunmi, Babatunde ; Buchenberger, Daniel ; Scherzer, Jenny...
European Journal of Public Health.  31 (2021)  3 - p. 567-575 , 2021
Link: https://doi.org/10.1093/..
 
?
11

Qualitative Thematic Analysis of Social Media Data to Asses..:

Matza, Louis S. ; Paulus, Trena M. ; Garris, Cindy P....
The Patient - Patient-Centered Outcomes Research.  13 (2020)  4 - p. 409-422 , 2020
Link: https://doi.org/10.1007/..
 
?
12

1035. Patient-Reported Outcomes on Long-Acting Cabotegravir..:

Chounta, Vasiliki ; Bernal, Enrique ; Lombaard, Johan...
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S548-S548 , 2020
Link: https://doi.org/10.1093/..
 
?
13

Patient-Reported Outcomes in ATLAS and FLAIR Participants o..:

Murray, Miranda ; Antela, Antonio ; Mills, Anthony...
AIDS and Behavior.  24 (2020)  12 - p. 3533-3544 , 2020
Link: https://doi.org/10.1007/..
 
?
14

Quantifying people living with HIV who would benefit from a..:

Clark, Laura ; Karki, Chitra ; Noone, Josh...
Population Medicine.  2 (2020)  October - p. 1-18 , 2020
Link: https://doi.org/10.18332..
 
?
15

Long-acting cabotegravir and rilpivirine dosed every 2 mont..:

Overton, Edgar T ; Richmond, Gary ; Rizzardini, Giuliano...
The Lancet.  396 (2020)  10267 - p. 1994-2005 , 2020
Link: https://doi.org/10.1016/..
 
1-15